201 related articles for article (PubMed ID: 3899029)
1. A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
Holmes EC; Hill LD; Gail M
Ann Surg; 1985 Sep; 202(3):335-41. PubMed ID: 3899029
[TBL] [Abstract][Full Text] [Related]
2. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma.
Holmes EC
Chest; 1994 Dec; 106(6 Suppl):293S-296S. PubMed ID: 7988247
[TBL] [Abstract][Full Text] [Related]
3. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
Holmes EC; Gail M
J Clin Oncol; 1986 May; 4(5):710-5. PubMed ID: 3009726
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).
Dautzenberg B; Chastang C; Arriagada R; Le Chevalier T; Belpomme D; Hurdebourcq M; Lebeau B; Fabre C; Charvolin P; Guérin RA
Cancer; 1995 Sep; 76(5):779-86. PubMed ID: 8625180
[TBL] [Abstract][Full Text] [Related]
5. Postoperative chemotherapy for non-small-cell lung cancer.
Holmes EC
Chest; 1993 Jan; 103(1 Suppl):30S-34S. PubMed ID: 8380131
[TBL] [Abstract][Full Text] [Related]
6. Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence.
Sadeghi A; Payne D; Rubinstein L; Lad T
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):89-97. PubMed ID: 2839444
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of intrapleural bacillus Calmette-Guerin with or without adjuvant chemotherapy in completely resected stages II and III non-small-cell lung cancer.
Macchiarini P; Hardin M; Angeletti CA
Am J Clin Oncol; 1991 Aug; 14(4):291-7. PubMed ID: 1650528
[TBL] [Abstract][Full Text] [Related]
8. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
J Clin Oncol; 1988 Jan; 6(1):9-17. PubMed ID: 2891798
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
10. A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non-small cell carcinoma of the lung.
Figlin RA; Piantodosi S
Chest; 1994 Dec; 106(6 Suppl):310S-312S. PubMed ID: 7988251
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer.
Gröhn P; Heinonen E; Klefström P; Tarkkanen J
Cancer; 1984 Aug; 54(4):670-4. PubMed ID: 6744203
[TBL] [Abstract][Full Text] [Related]
12. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
Maurer LH; Pajak T; Eaton W; Comis R; Chahinian P; Faulkner C; Silberfarb PM; Henderson E; Rege VB; Baldwin PE
J Clin Oncol; 1985 Jul; 3(7):969-76. PubMed ID: 2991478
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
Feld R; Rubinstein L; Thomas PA
Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
[TBL] [Abstract][Full Text] [Related]
14. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
Kimura H; Yamaguchi Y
Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma.
Smith MR; Peters WA; Drescher CW
Am J Obstet Gynecol; 1994 Jun; 170(6):1677-81; discussion 1681-2. PubMed ID: 8203425
[TBL] [Abstract][Full Text] [Related]
16. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
17. Surgical adjuvant chemotherapy in non-small cell lung cancer.
Holmes EC
Semin Oncol; 1988 Jun; 15(3):255-60. PubMed ID: 2837830
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
[TBL] [Abstract][Full Text] [Related]
19. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
